Race Oncology Ltd (ASX:RAC, OTC:RAONF) has appointed experienced corporate and financial executive Brendan Brown as its chief financial officer (CFO), effective from Monday, April 1, 2024.
Brown is a partner and director of Prime Accounting & Business Advisory Pty Ltd, part of the Prime Financial Group, which has a working relationship with Race Oncology.
He brings significant practical experience to Race having worked with numerous life science clients through the past 20 years and succeeds Christina Manfre of PKF Sydney Pty Ltd in the CFO role.
“Expanding engagement”
Chief executive officer Daniel Tillett said: “We thank Christina for her time with Race and welcome Brendan to his new role as Race CFO.
"Race has had a productive working relationship with Prime over the last two years, being responsible for Race’s successful R&D Tax Incentive claims.
"We are pleased to be expanding our engagement with both Brendan and Prime as we advance our new formulation of bisantrene in the clinic in 2024,” he added.
Brown is a Chartered Accountant (CA ANZ) and Registered Tax Agent with a Bachelor of Commerce (Accounting) from La Trobe University.